Schedule 13D ownership disclosure
Tracon Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 89237H100
Event date: 2015-02-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 15.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-15-000081
- Form type
- SC 13D
- Filer
- New Enterprise Associates 14, L.P.
- CIK
- CIK 1544328
- Filed
- Feb 11, 2015
- Reporting period
- Feb 04, 2015
- Description
- Schedule 13D beneficial ownership